Concepedia

R Aultman

RA

7

Publications

140

Citations

7

H-Index

2004

Active since

Affiliations

Roche (Switzerland)(Current)

Medizinische Hochschule Hannover

R Aultman is an author at Roche (Switzerland) specializing in public health, health economics, and medicine.

Top concepts

MedicinePublic HealthHealth EconomicsHealth PolicyInfection ControlOutcomes ResearchEconomic EvaluationHealthOncologyPediatrics

Publications per year

2004–2010

7

Publications

7

Cost-Effectiveness of Erlotinib versus Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in the United Kingdom

G Lewis, Michael Peake, R Aultman et al. · Journal of International Medical Research · 2010 · 43 citations

Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children

Keith S. Reisinger, Gerald R. Greene, R Aultman et al. · Clinical Drug Investigation · 2004 · 24 citations

Otherwise Healthy Children, Health Economics, Health Outcome +8

Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer

Mark Nuijten, David F. Heigener, Helge Bischoff et al. · Lung Cancer · 2010 · 17 citations

Oncology, Pemetrexed-cisplatin Treatment, Immune Checkpoint Inhibitor +4

Patient‐reported health care utilization in rheumatoid arthritis: What level of detail is required?

Jörg Ruof, Jan L. Huelsemann, Thomas Mittendorf et al. · Arthritis Care & Research · 2004 · 17 citations

A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma

R. E. Marcus, R Aultman, F Jost · British Journal of Cancer · 2009 · 16 citations · Full text

Rows per page

1–5 of 7